---
title: "LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-Driven Antibody Optimisation Programs"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/268563449.md"
description: "LabGenius Therapeutics announced a second collaboration with Sanofi. This collaboration combines LabGenius' AI/ML-driven antibody design capabilities with Sanofi's expertise in the development of therapeutic NANOBODY molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collaboration, LabGenius will apply the EVA platform to optimise NANOBODY molecules for multiple new targets in the area of inflammation."
datetime: "2025-12-04T09:10:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/268563449.md)
  - [en](https://longbridge.com/en/news/268563449.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/268563449.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/268563449.md) | [English](https://longbridge.com/en/news/268563449.md)


# LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-Driven Antibody Optimisation Programs

LabGenius Therapeutics announced a second collaboration with Sanofi. This collaboration combines LabGenius' AI/ML-driven antibody design capabilities with Sanofi's expertise in the development of therapeutic NANOBODY molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collaboration, LabGenius will apply the EVA platform to optimise NANOBODY molecules for multiple new targets in the area of inflammation.

### 相關股票

- [Sanofi (SNYNF.US)](https://longbridge.com/zh-HK/quote/SNYNF.US.md)

## 相關資訊與研究

- [Sanofi’s Sarclisa Subcutaneous Formulation Via On-Body Injector Recommended For EU Approval](https://longbridge.com/zh-HK/news/280786871.md)
- [Sanofi Secures EU Conditional Marketing Approval for Graft-vs-Host Disease Medicine](https://longbridge.com/zh-HK/news/281129645.md)
- [Insig AI Plans Growth Drive and Eyes Nasdaq Dual Listing](https://longbridge.com/zh-HK/news/281311983.md)
- [Lattice Acquires Mandala Technology, Advancing the New Way to Work with People + AI](https://longbridge.com/zh-HK/news/281231794.md)
- [ThinkLabs AI Inc. announced that it has received $28 million in funding from a group of investors](https://longbridge.com/zh-HK/news/281232714.md)